83 related articles for article (PubMed ID: 26430163)
21. Oncogenic pathways in hereditary and sporadic breast cancer.
Kenemans P; Verstraeten RA; Verheijen RH
Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
[TBL] [Abstract][Full Text] [Related]
22. The breast cancer somatic 'muta-ome': tackling the complexity.
Teschendorff AE; Caldas C
Breast Cancer Res; 2009; 11(2):301. PubMed ID: 19344493
[TBL] [Abstract][Full Text] [Related]
23. Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer.
Forsberg LA; Rasi C; Pekar G; Davies H; Piotrowski A; Absher D; Razzaghian HR; Ambicka A; Halaszka K; Przewoźnik M; Kruczak A; Mandava G; Pasupulati S; Hacker J; Prakash KR; Dasari RC; Lau J; Penagos-Tafurt N; Olofsson HM; Hallberg G; Skotnicki P; Mituś J; Skokowski J; Jankowski M; Śrutek E; Zegarski W; Tiensuu Janson E; Ryś J; Tot T; Dumanski JP
Genome Res; 2015 Oct; 25(10):1521-35. PubMed ID: 26430163
[TBL] [Abstract][Full Text] [Related]
24. Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.
Grob TJ; Heilenkötter U; Geist S; Paluchowski P; Wilke C; Jaenicke F; Quaas A; Wilczak W; Choschzick M; Sauter G; Lebeau A
Breast Cancer Res Treat; 2012 Jul; 134(2):561-7. PubMed ID: 22610646
[TBL] [Abstract][Full Text] [Related]
25. Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification.
Van Bockstal MR; Agahozo MC; van Marion R; Atmodimedjo PN; Sleddens HFBM; Dinjens WNM; Visser LL; Lips EH; Wesseling J; van Deurzen CHM
Mol Oncol; 2020 Apr; 14(4):671-685. PubMed ID: 32058674
[TBL] [Abstract][Full Text] [Related]
26. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
[TBL] [Abstract][Full Text] [Related]
27. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
[TBL] [Abstract][Full Text] [Related]
28. Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number.
Mrhalová M; Kodet R; Kalinová M; Hilská I
Pathol Res Pract; 2003; 199(7):453-61. PubMed ID: 14521261
[TBL] [Abstract][Full Text] [Related]
29. Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients.
Ronowicz A; Janaszak-Jasiecka A; Skokowski J; Madanecki P; Bartoszewski R; Bałut M; Seroczyńska B; Kochan K; Bogdan A; Butkus M; Pęksa R; Ratajska M; Kuźniacka A; Wasąg B; Gucwa M; Krzyżanowski M; Jaśkiewicz J; Jankowski Z; Forsberg L; Ochocka JR; Limon J; Crowley MR; Buckley PG; Messiaen L; Dumanski JP; Piotrowski A
Hum Mutat; 2015 Nov; 36(11):1088-99. PubMed ID: 26219265
[TBL] [Abstract][Full Text] [Related]
30. Biobanking multifocal breast carcinomas: sample adequacy with regard to histology and DNA content.
Pekar G; Davies H; Lukacs AP; Forsberg L; Hellberg D; Dumanski J; Tot T
Histopathology; 2016 Feb; 68(3):411-21. PubMed ID: 26083274
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.
Cooper CS; Eeles R; Wedge DC; Van Loo P; Gundem G; Alexandrov LB; Kremeyer B; Butler A; Lynch AG; Camacho N; Massie CE; Kay J; Luxton HJ; Edwards S; Kote-Jarai Z; Dennis N; Merson S; Leongamornlert D; Zamora J; Corbishley C; Thomas S; Nik-Zainal S; O'Meara S; Matthews L; Clark J; Hurst R; Mithen R; Bristow RG; Boutros PC; Fraser M; Cooke S; Raine K; Jones D; Menzies A; Stebbings L; Hinton J; Teague J; McLaren S; Mudie L; Hardy C; Anderson E; Joseph O; Goody V; Robinson B; Maddison M; Gamble S; Greenman C; Berney D; Hazell S; Livni N; ; Fisher C; Ogden C; Kumar P; Thompson A; Woodhouse C; Nicol D; Mayer E; Dudderidge T; Shah NC; Gnanapragasam V; Voet T; Campbell P; Futreal A; Easton D; Warren AY; Foster CS; Stratton MR; Whitaker HC; McDermott U; Brewer DS; Neal DE
Nat Genet; 2015 Apr; 47(4):367-372. PubMed ID: 25730763
[TBL] [Abstract][Full Text] [Related]
32. Detection of leukemia-associated mutations in peripheral blood DNA of hematologically normal elderly individuals.
Score J; Chase A; Forsberg LA; Feng L; Waghorn K; Jones AV; Rasi C; Linch DC; Dumanski JP; Gale RE; Cross NC
Leukemia; 2015 Jul; 29(7):1600-2. PubMed ID: 25627638
[No Abstract] [Full Text] [Related]
33. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer.
Forsberg LA; Rasi C; Malmqvist N; Davies H; Pasupulati S; Pakalapati G; Sandgren J; Diaz de Ståhl T; Zaghlool A; Giedraitis V; Lannfelt L; Score J; Cross NC; Absher D; Janson ET; Lindgren CM; Morris AP; Ingelsson E; Lind L; Dumanski JP
Nat Genet; 2014 Jun; 46(6):624-8. PubMed ID: 24777449
[TBL] [Abstract][Full Text] [Related]
34. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis.
Holstege H; Pfeiffer W; Sie D; Hulsman M; Nicholas TJ; Lee CC; Ross T; Lin J; Miller MA; Ylstra B; Meijers-Heijboer H; Brugman MH; Staal FJ; Holstege G; Reinders MJ; Harkins TT; Levy S; Sistermans EA
Genome Res; 2014 May; 24(5):733-42. PubMed ID: 24760347
[TBL] [Abstract][Full Text] [Related]
35. First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.
Sörensen J; Sandberg D; Sandström M; Wennborg A; Feldwisch J; Tolmachev V; Åström G; Lubberink M; Garske-Román U; Carlsson J; Lindman H
J Nucl Med; 2014 May; 55(5):730-5. PubMed ID: 24665085
[TBL] [Abstract][Full Text] [Related]
36. Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.
Mortimer JE; Bading JR; Colcher DM; Conti PS; Frankel PH; Carroll MI; Tong S; Poku E; Miles JK; Shively JE; Raubitschek AA
J Nucl Med; 2014 Jan; 55(1):23-9. PubMed ID: 24337604
[TBL] [Abstract][Full Text] [Related]
37. Genetic clonal mapping of in situ and invasive ductal carcinoma indicates the field cancerization phenomenon in the breast.
Foschini MP; Morandi L; Leonardi E; Flamminio F; Ishikawa Y; Masetti R; Eusebi V
Hum Pathol; 2013 Jul; 44(7):1310-9. PubMed ID: 23337025
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
